KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Long-Term Investments (2017 - 2025)

Moderna (MRNA) has disclosed Long-Term Investments for 9 consecutive years, with $2.3 billion as the latest value for Q4 2025.

  • On a quarterly basis, Long-Term Investments fell 6.34% to $2.3 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $2.3 billion, a 6.34% decrease, with the full-year FY2025 number at $2.3 billion, down 6.34% from a year prior.
  • Long-Term Investments was $2.3 billion for Q4 2025 at Moderna, down from $2.4 billion in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $10.2 billion in Q2 2022 to a low of $36.0 million in Q1 2023.
  • A 5-year average of $4.8 billion and a median of $4.4 billion in 2021 define the central range for Long-Term Investments.
  • Peak YoY movement for Long-Term Investments: skyrocketed 1859.62% in 2022, then plummeted 99.61% in 2023.
  • Moderna's Long-Term Investments stood at $6.8 billion in 2021, then rose by 21.55% to $8.3 billion in 2022, then tumbled by 43.77% to $4.7 billion in 2023, then plummeted by 46.68% to $2.5 billion in 2024, then dropped by 6.34% to $2.3 billion in 2025.
  • Per Business Quant, the three most recent readings for MRNA's Long-Term Investments are $2.3 billion (Q4 2025), $2.4 billion (Q2 2025), and $2.4 billion (Q1 2025).